Comparison of different lipid abnormalities between hemodialysis and peritoneal dialysis in patients with ESRD
Biomedicine Advances · 2025
DOI: 10.34172/bma.13 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedicine Advances, 2025. Verfasst von Naimeh Mesri Alamdari und 3 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben.
Abstract (Originalsprache)
Background: cardiovascular disease is the most common cause of death in patients with chronic kidney disease. Abnormalities of plasma lipids and lipoproteins are the underling cause in chronic kidney disease (CKD) patients. This study aimed to determine the prevalence of lipid disorders in end-stage renal disease (ESRD) patients undergoing hemodialysis (HD) and peritoneal dialysis and compare them between two groups.
Methods
This cross-sectional study evaluated the lipid profile of 300 ESRD patients (150 HD and 150 PD) at baseline and one year after dialysis using the patients’ documents.
Findings
One year after dialysis, serum total cholesterol, triglyceride (TG), and low-density lipoprotein cholesterol (LDL-C) levels were significantly higher in patients undergoing PD in comparison with HD groups (195.57±47.61 mg /dL vs. 157.89±44.04 mg /dL (P
Zitieren
APA
Alamdari, N. M., Allahverdikhan-Vaziri, S., Rahimi, M., & Sadra, V. (2025). Comparison of different lipid abnormalities between hemodialysis and peritoneal dialysis in patients with ESRD. Biomedicine Advances. https://doi.org/10.34172/bma.13
Vancouver
Alamdari NM, Allahverdikhan-Vaziri S, Rahimi M, Sadra V. Comparison of different lipid abnormalities between hemodialysis and peritoneal dialysis in patients with ESRD. Biomedicine Advances. 2025. doi:10.34172/bma.13
BibTeX
@article{Alamdari2025,
author = {Alamdari, Naimeh Mesri and Allahverdikhan-Vaziri, Sahar and Rahimi, Mehran and Sadra, Vahideh},
title = {Comparison of different lipid abnormalities between hemodialysis and peritoneal dialysis in patients with ESRD},
journal = {Biomedicine Advances},
year = {2025},
doi = {10.34172/bma.13}
}
EUVIMED